Ancheng Biotechnology Co., Ltd. (hereinafter referred to as Ancheng Biotech) is a new drug research and development company headquartered in Taipei, Taiwan, which develops and treats rare diseases. The strategy is to re-position the drug molecules already in clinical use. There is no need for good medicine or emerging medicines, especially for rarediseases that are severely and drug-free. They aim to be efficient and innovative, providing safe and effective new drugs to patients in need around the world.